Medicare Enrolled
Dr. Ryan Devine, DO
Medical Oncology · Jupiter, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Devine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Devine?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Devine
Dr. Ryan Devine is a medical oncology specialist in Jupiter, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Devine performed 505 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Devine received a total of $11,002 from 75 pharmaceutical and/or device companies across 561 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Devine is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ 505 Medicare services
$11,002 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 16151 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗505
Medicare services
Bottom 34% in FL for medical oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
240 | $104 | $377 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
88 | $144 | $528 |
| New patient office visit, complex (60-74 min) | 53 | $168 | $600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $126 | $453 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $61 | $214 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
26 | $96 | $304 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $64 | $232 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,002
Total received (2018-2024)
Avg $1,572/year across 7 years
Top 41% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
561
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$562
2023
$69
2022
$2,753
2021
$2,317
2020
$3,328
2019
$1,637
2018
$335
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$175
GlaxoSmithKline, LLC.
$109
PFIZER INC.
$78
E.R. Squibb & Sons, L.L.C.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$27
Eisai Inc.
$26
PharmaEssentia USA Corporation
$25
Ferring Pharmaceuticals Inc.
$22
Kyowa Kirin, Inc.
$21
Celgene Corporation
$20
Janssen Pharmaceuticals, Inc
$20
Top 3 companies account for 64.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,408
E.R. Squibb & Sons, L.L.C.
$806
PFIZER INC.
$681
Incyte Corporation
$529
Merck Sharp & Dohme Corporation
$487
Amgen Inc.
$416
Lilly USA, LLC
$416
Astellas Pharma US Inc
$358
Seagen Inc.
$333
Sirtex Medical Inc
$322
Janssen Biotech, Inc.
$320
Daiichi Sankyo Inc.
$309
GENZYME CORPORATION
$273
Novartis Pharmaceuticals Corporation
$248
GlaxoSmithKline, LLC.
$238
Dova Pharmaceuticals
$233
JAZZ PHARMACEUTICALS INC.
$223
Genentech USA, Inc.
$201
Celgene Corporation
$197
Bayer HealthCare Pharmaceuticals Inc.
$175
Coherus Biosciences Inc.
$145
Exelixis Inc.
$126
Novocure Inc.
$125
Ipsen Biopharmaceuticals, Inc
$119
Merck Sharp & Dohme LLC
$110
Karyopharm Therapeutics Inc.
$104
Eisai Inc.
$94
ARRAY BIOPHARMA INC
$93
EISAI INC.
$92
Seattle Genetics, Inc.
$92
Puma Biotechnology, Inc.
$91
ABBVIE INC.
$90
PUMA BIOTECHNOLOGY, INC.
$88
Alnylam Pharmaceuticals Inc.
$71
AbbVie Inc.
$68
Deciphera Pharmaceuticals Inc.
$68
Foundation Medicine, Inc.
$63
AbbVie, Inc.
$61
Pharmacyclics LLC, An AbbVie Company
$59
Regeneron Healthcare Solutions, Inc.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
TOLMAR Pharmaceuticals, Inc.
$53
PharmaEssentia USA Corporation
$51
Takeda Pharmaceuticals U.S.A., Inc.
$51
TG THERAPEUTICS, INC.
$44
Taiho Oncology, Inc.
$42
Alexion Pharmaceuticals, Inc.
$41
RECORDATI_RARE_DISEASES_INC.
$41
Sobi, Inc
$41
Mylan Institutional Inc.
$39
Advanced Accelerator Applications
$36
Kyowa Kirin, Inc.
$35
BeiGene USA, Inc.
$34
Organon LLC
$32
EMD Serono, Inc.
$32
Kite Pharma, Inc.
$31
Global Blood Therapeutics, Inc.
$27
Epizyme, Inc.,
$26
Emmaus Medical, Inc.
$23
EUSA Pharma (US) LLC
$22
Ferring Pharmaceuticals Inc.
$22
Myriad Genetic Laboratories, Inc.
$22
Clovis Oncology, Inc.
$22
Jazz Pharmaceuticals Inc.
$21
Janssen Pharmaceuticals, Inc
$20
TG Therapeutics, Inc.
$20
Sun Pharmaceutical Industries Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$16
Agios Pharmaceuticals, Inc.
$16
Verastem, Inc.
$16
Pharmacyclics LLC, an AbbVie Company
$15
Aveo Pharmaceuticals, Inc.
$15
Lexicon Pharmaceuticals, Inc.
$14
Acceleron Pharma, Inc.
$14
Octapharma USA, Inc.
$12
Top 3 companies account for 26.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADSTILADRIN · AKYNZEO · ALIMTA · AUGTYRO · Avastin · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARBAGLU · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Endari · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · Fulphila · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONPATTRO · ONTRUZANT · ONUREG · OPDIVO · OXBRYTA · Ogivri · Optune · PADCEV · PANHEMATIN · PEMAZYRE · PIQRAY · POLIVY · POTELIGEO · PROMACTA · PYRUKYND · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rubraca · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TAZVERIK · TECENTRIQ · TUKYSA · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · YONSA · ZEJULA · ZEPZELCA · myChoice CDx
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
19
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
JUPITER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Devine is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Devine experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Devine performed 240 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Devine receive payments from pharmaceutical companies?
Yes. Dr. Devine received a total of $11,002 from 75 companies across 561 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Devine's costs compare to other medical oncologists in Jupiter?
Dr. Devine's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Devine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Jupiter
Browse medical oncologists in Jupiter ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology